When it comes to breast cancer, Hispanic women or Latinas are more likely to be diagnosed at more advanced stages, which are harder to treat. They’re also more likely to have aggressive forms of the disease, such as triple negative and HER2-positive breast cancers.
Laura Fejerman, PhD, is among those working to increase breast cancer awareness and breast cancer screening among Hispanic women or Latinas. She is co-director of the Women’s Cancer Care and Research Program at the UC Davis Comprehensive Cancer Center. In 2014, Fejerman and her colleagues discovered a gene variant in Hispanic women or Latinas that was…
